Supplement for persistent HPV infection
Part of Infections clinical trials.
This study tests whether a daily supplement with green tea extract, folic acid, vitamin B12, and hyaluronic acid can help clear a persistent HPV infection and prevent cervical lesions from getting worse. It may be an option for people who have had a low-grade cervical lesion and have already been vaccinated against HPV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 25 years or older.
- You have tested positive for HPV (with genotyping) both 9-24 months ago and again at the start of the study.
- You have had a low-grade cervical lesion (such as LSIL or ASC-US on a Pap test, or a low-grade finding on colposcopy or biopsy) within the past 5-24 months.
- You have completed HPV vaccination at least 24 months before the study starts.
- You are not pregnant or breastfeeding, and you have no severe immune system problems.
- You do not take other green tea products daily and are not allergic to the supplement ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a combination of EGCG (a compound from green tea), folic acid, and vitamin B12 can help prevent an HPV infection from lasting or getting worse. You may be able to join if you have a high-risk HPV infection but not a more serious cervical cell change called HSIL.
This trial tests whether a daily supplement with green tea extract (EGCG), vitamin B12, hyaluronic acid, and folic acid can help the body's natural defenses fight HPV infection in men. It may be useful for couples trying to conceive where the male partner has an active HPV infection.
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This study compares two treatments—photodynamic therapy using a special light-activated cream and a CO2 laser—to see which works better for clearing low-grade cervical changes caused by a long-lasting high-risk HPV infection. The goal is to find a safe, effective option for women who have had this condition for over a year.
This study tests whether a daily supplement (with green tea extract, folic acid, and vitamins) can help clear HPV in men and support genital health. It is designed for couples trying to conceive, where only the male has an active HPV infection.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.